PRO 140 in Treatment-Experienced HIV-1 Subjects
Study sponsor: CytoDyn, Inc.
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2020-05-18Actual
Enrollment · participants6Actual
Source updated2025-09-16Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.